{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:20:29Z","timestamp":1787872829608,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Hubei Provinc","award":["2023AFD045"],"award-info":[{"award-number":["2023AFD045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55954-3","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T12:45:19Z","timestamp":1781354719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of TBXAS1 as a candidate biomarker and potential microglia-associated inflammatory regulator in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaoxue","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuneng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"55954_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa, E., Garrido, A., Scholz, S. W. & Poewe, W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 20, 385\u2013397 (2021).","journal-title":"Lancet Neurol."},{"key":"55954_CR2","doi-asserted-by":"publisher","first-page":"31167","DOI":"10.1038\/s41598-024-82470-z","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Multi-omics analysis reveals the genetic aging landscape of Parkinson\u2019s disease. Sci. Rep. 14, 31167 (2024).","journal-title":"Sci. Rep."},{"key":"55954_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41401-020-0365-y","volume":"41","author":"Q Mao","year":"2020","unstructured":"Mao, Q., Qin, W., Zhang, A. & Ye, N. Recent advances in dopaminergic strategies for the treatment of Parkinson\u2019s disease. Acta Pharmacol. Sin. 41, 471\u2013482 (2020).","journal-title":"Acta Pharmacol. Sin"},{"key":"55954_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41421-021-00280-3","volume":"7","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson\u2019s disease. Cell. Discov. 7, 52 (2021).","journal-title":"Cell. Discov"},{"key":"55954_CR5","doi-asserted-by":"publisher","first-page":"1656729","DOI":"10.3389\/fimmu.2025.1656729","volume":"16","author":"Q Miao","year":"2025","unstructured":"Miao, Q., Wang, T., Wang, H., Yu, Y. & Jin, X. Loss of DJ-1 alleviates microglia-mediated neuroinflammation in Parkinson\u2019s disease via autophagy-lysosomal degradation of NLRP3. Front. Immunol. 16, 1656729 (2025).","journal-title":"Front. Immunol."},{"key":"55954_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","volume":"39","author":"E \u00c7\u0131nar","year":"2022","unstructured":"\u00c7\u0131nar, E., Tel, B. C. & \u015eahin, G. Neuroinflammation in Parkinson\u2019s disease and its treatment opportunities. Balkan Med. J. 39, 318\u2013333 (2022).","journal-title":"Balkan Med. J."},{"key":"55954_CR7","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s11064-022-03713-x","volume":"47","author":"EJR De Almeida","year":"2022","unstructured":"De Almeida, E. J. R., Ibrahim, H. J., Chitolina Schetinger, M. R., De Andrade, C. M. & Cardoso, A. M. Modulation of inflammatory mediators and microglial activation through physical exercise in Alzheimer\u2019s and Parkinson\u2019s diseases. Neurochem Res. 47, 3221\u20133240 (2022).","journal-title":"Neurochem Res."},{"key":"55954_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1742-2094-8-95","volume":"8","author":"YP Wang","year":"2011","unstructured":"Wang, Y. P. et al. Aspirin-triggered lipoxin A4attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-\u03baB and MAPKs in BV-2 microglial cells. J. Neuroinflammation. 8, 95 (2011).","journal-title":"J. Neuroinflammation"},{"key":"55954_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41598-017-18786-w","volume":"8","author":"L Sun","year":"2018","unstructured":"Sun, L. et al. Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death. Sci. Rep. 8, 383 (2018).","journal-title":"Sci. Rep."},{"key":"55954_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molimm.2019.09.020","volume":"116","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2\/ TLR4\/ NF-\u03baB pathways in BV2 cells. Mol. Immunol. 116, 29\u201337 (2019).","journal-title":"Mol. Immunol."},{"key":"55954_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"55954_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-024-00402-3","volume":"13","author":"C Rim","year":"2024","unstructured":"Rim, C., You, M. J., Nahm, M. & Kwon, M. S. Emerging role of senescent microglia in brain aging-related neurodegenerative diseases. Transl Neurodegener. 13, 10 (2024).","journal-title":"Transl Neurodegener"},{"key":"55954_CR13","doi-asserted-by":"publisher","first-page":"1659947","DOI":"10.3389\/fimmu.2025.1659947","volume":"16","author":"L M\u00fcller","year":"2025","unstructured":"M\u00fcller, L., Di Benedetto, S. & M\u00fcller, V. The dual nature of neuroinflammation in networked brain. Front. Immunol. 16, 1659947 (2025).","journal-title":"Front. Immunol."},{"key":"55954_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12967-025-06296-7","volume":"23","author":"XX Zhu","year":"2025","unstructured":"Zhu, X. X. et al. Transcriptomic profiling identifies ferroptosis and NF-\u03baB signaling involved in \u03b1-dimorphecolic acid regulation of microglial inflammation. J. Transl Med. 23, 260 (2025).","journal-title":"J. Transl Med."},{"key":"55954_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12974-025-03462-y","volume":"22","author":"F Lind-Holm Mogensen","year":"2025","unstructured":"Lind-Holm Mogensen, F., Seibler, P., Gr\u00fcnewald, A. & Michelucci, A. Microglial dynamics and neuroinflammation in prodromal and early Parkinson\u2019s disease. J. Neuroinflammation. 22, 136 (2025).","journal-title":"J. Neuroinflammation"},{"key":"55954_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.abb8587","volume":"370","author":"T Bartels","year":"2020","unstructured":"Bartels, T., De Schepper, S. & Hong, S. Microglia modulate neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases. Science 370, 66\u201369 (2020).","journal-title":"Science"},{"key":"55954_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","volume":"11","author":"JM Lawrence","year":"2023","unstructured":"Lawrence, J. M., Schardien, K., Wigdahl, B. & Nonnemacher, M. R. Roles of neuropathology-associated reactive astrocytes: A systematic review. Acta Neuropathol. Commun. 11, 42 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"55954_CR18","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/life15101498","volume":"15","author":"M Garc\u00eda-Dom\u00ednguez","year":"2025","unstructured":"Garc\u00eda-Dom\u00ednguez, M. Interplay between aging and glial cell dysfunction: Implications for CNS health. Life 15, 1498 (2025).","journal-title":"Life"},{"key":"55954_CR19","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares, M., Rojo, I., Manda, A., Bosc\u00e1, G., Cuadrado, A. & L. & Inflammation in Parkinson\u2019s disease: Mechanisms and therapeutic implications. Cells 9, 1687 (2020).","journal-title":"Cells"},{"key":"55954_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/ijms27010486","volume":"27","author":"S Ahmed","year":"2026","unstructured":"Ahmed, S., Pasam, T. & Afreen, F. Mitophagy\u2013NLRP3 inflammasome crosstalk in Parkinson\u2019s disease: Pathogenic mechanisms and emerging therapeutic strategies. IJMS 27, 486 (2026).","journal-title":"IJMS"},{"key":"55954_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-023-00699-0","volume":"19","author":"A Martirosyan","year":"2024","unstructured":"Martirosyan, A. et al. Unravelling cell type-specific responses to Parkinson\u2019s disease at single cell resolution. Mol. Neurodegener. 19, 7 (2024).","journal-title":"Mol. Neurodegener"},{"key":"55954_CR22","unstructured":"Zhang, L. Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease Brains."},{"key":"55954_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41531-023-00527-8","volume":"9","author":"X Guo","year":"2023","unstructured":"Guo, X. et al. Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson\u2019s disease based on integrative analysis. npj Parkinsons Dis. 9, 82 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"55954_CR24","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1038\/s41467-019-13144-y","volume":"10","author":"Q Wang","year":"2019","unstructured":"Wang, Q. et al. The landscape of multiscale transcriptomic networks and key regulators in Parkinson\u2019s disease. Nat. Commun. 10, 5234 (2019).","journal-title":"Nat. Commun."},{"key":"55954_CR25","doi-asserted-by":"publisher","first-page":"eabo1997","DOI":"10.1126\/scitranslmed.abo1997","volume":"16","author":"B Zhu","year":"2024","unstructured":"Zhu, B. et al. Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease brains. Sci. Transl Med. 16, eabo1997 (2024).","journal-title":"Sci. Transl Med."},{"key":"55954_CR26","doi-asserted-by":"publisher","first-page":"1345321","DOI":"10.3389\/fimmu.2024.1345321","volume":"15","author":"Q Lin","year":"2024","unstructured":"Lin, Q. et al. Prognostic stratification of sepsis through DNA damage response based RiskScore system: insights from single-cell RNA-sequencing and transcriptomic profiling. Front. Immunol. 15, 1345321 (2024).","journal-title":"Front. Immunol."},{"key":"55954_CR27","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"55954_CR28","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.2174\/1389557523666230511122435","volume":"23","author":"S Jain","year":"2023","unstructured":"Jain, S., Singh, R., Paliwal, S. & Sharma, S. Targeting neuroinflammation as disease modifying approach to Alzheimer\u2019s disease: Potential and challenges. MRMC 23, 2097\u20132116 (2023).","journal-title":"MRMC"},{"key":"55954_CR29","doi-asserted-by":"publisher","first-page":"1439125","DOI":"10.3389\/fneur.2024.1439125","volume":"15","author":"Y Cantero-Fortiz","year":"2024","unstructured":"Cantero-Fortiz, Y. & Boada, M. The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer\u2019s, and Parkinson\u2019s disease\u2019. Front. Neurol. 15, 1439125 (2024).","journal-title":"Front. Neurol."},{"key":"55954_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41398-024-02777-3","volume":"14","author":"K Park","year":"2024","unstructured":"Park, K. et al. Genome-wide association study implicates the role of TBXAS1 in the pathogenesis of depressive symptoms among the Korean population. Transl Psychiatry. 14, 80 (2024).","journal-title":"Transl Psychiatry"},{"key":"55954_CR31","doi-asserted-by":"publisher","first-page":"1519529","DOI":"10.3389\/fgene.2024.1519529","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Integration of single-cell and bulk analysis reveals TBXAS1 as a key platelet-related gene causing poor prognosis in osteosarcoma. Front. Genet. 15, 1519529 (2024).","journal-title":"Front. Genet."},{"key":"55954_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.biochi.2025.04.003","volume":"234","author":"PV Ershov","year":"2025","unstructured":"Ershov, P. V., Yablokov, E. O., Mezentsev, Y. V. & Ivanov, A. S. Human prostacyclin and thromboxane synthases: Molecular interactions, regulation, and pharmacology. Biochimie 234, 76\u201388 (2025).","journal-title":"Biochimie"},{"key":"55954_CR33","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt, C. et al. The immune system in Parkinson\u2019s disease: What we know so far. Brain 147, 3306\u20133324 (2024).","journal-title":"Brain"},{"key":"55954_CR34","doi-asserted-by":"publisher","first-page":"8336","DOI":"10.3390\/ijms26178336","volume":"26","author":"Z Li","year":"2025","unstructured":"Li, Z., Li, M., Fang, Z. & Wang, H. Immunological mechanisms and therapeutic strategies in cerebral ischemia\u2013reperfusion injury: From inflammatory response to neurorepair. IJMS 26, 8336 (2025).","journal-title":"IJMS"},{"key":"55954_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/jnnp-2013-305420","volume":"85","author":"AJ Noyce","year":"2014","unstructured":"Noyce, A. J. et al. PREDICT-PD: Identifying risk of Parkinson\u2019s disease in the community: Methods and baseline results. J. Neurol. Neurosurg. Psychiatry. 85, 31\u201337 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"55954_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/dnares\/dsl016","volume":"13","author":"JM Kim","year":"2006","unstructured":"Kim, J. M. et al. Identification of genes related to Parkinson\u2019s disease using expressed sequence tags. DNA Res. 13, 275\u2013286 (2006).","journal-title":"DNA Res."},{"key":"55954_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/cells13060485","volume":"13","author":"S Anilkumar","year":"2024","unstructured":"Anilkumar, S. & Wright-Jin, E. NF-\u03baB as an inducible regulator of inflammation in the central nervous system. Cells 13, 485 (2024).","journal-title":"Cells"},{"key":"55954_CR38","doi-asserted-by":"publisher","first-page":"101017","DOI":"10.1016\/j.bbih.2025.101017","volume":"46","author":"S Chen","year":"2025","unstructured":"Chen, S., Crack, P. J. & Taylor, J. M. The contribution of type-I IFN-mediated neuroinflammation to Parkinson\u2019s disease progression. Brain Behav. Immun. Health. 46, 101017 (2025).","journal-title":"Brain Behav. Immun. Health"},{"key":"55954_CR39","doi-asserted-by":"publisher","first-page":"106801","DOI":"10.1016\/j.compbiomed.2023.106801","volume":"158","author":"S Yan","year":"2023","unstructured":"Yan, S. et al. Single-cell transcriptomics reveals the interaction between peripheral CD4\u2009+\u2009CTLs and mesencephalic endothelial cells mediated by IFNG in Parkinson\u2019s disease. Comput. Biol. Med. 158, 106801 (2023).","journal-title":"Comput. Biol. Med."},{"key":"55954_CR40","doi-asserted-by":"crossref","unstructured":"Andersson, E. R. et al. Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells. Proc. Natl. Acad. Sci. U.S.A. 110 (2013).","DOI":"10.1073\/pnas.1208524110"},{"key":"55954_CR41","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/s41467-023-39060-w","volume":"14","author":"AM Schonhoff","year":"2023","unstructured":"Schonhoff, A. M. et al. Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease. Nat. Commun. 14, 3754 (2023).","journal-title":"Nat. Commun."},{"key":"55954_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12974-023-02709-w","volume":"20","author":"R Zheng","year":"2023","unstructured":"Zheng, R. et al. ASC specks exacerbate \u03b1\u2013synuclein pathology via amplifying NLRP3 inflammasome activities. J. Neuroinflammation. 20, 26 (2023).","journal-title":"J. Neuroinflammation"},{"key":"55954_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbi.2024.03.038","volume":"119","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Pyroptosis-mediator GSDMD promotes Parkinson\u2019s disease pathology via microglial activation and dopaminergic neuronal death. Brain. Behav. Immun. 119, 129\u2013145 (2024).","journal-title":"Brain. Behav. Immun."},{"key":"55954_CR44","doi-asserted-by":"publisher","first-page":"115266","DOI":"10.1016\/j.celrep.2025.115266","volume":"44","author":"Q Ma","year":"2025","unstructured":"Ma, Q. et al. Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson\u2019s disease via the prosaposin-GPR37-IL-6 axis. Cell. Rep. 44, 115266 (2025).","journal-title":"Cell. Rep."},{"key":"55954_CR45","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.4049\/jimmunol.171.12.6389","volume":"171","author":"DW Thomas","year":"2003","unstructured":"Thomas, D. W. et al. Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. J. Immunol. 171, 6389\u20136395 (2003).","journal-title":"J. Immunol."},{"key":"55954_CR46","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.3390\/molecules27196234","volume":"27","author":"AW Ashton","year":"2022","unstructured":"Ashton, A. W., Zhang, Y., Cazzolli, R. & Honn, K. V. The role and regulation of thromboxane A2 signaling in cancer-trojan horses and misdirection. Molecules 27, 6234 (2022).","journal-title":"Molecules"},{"key":"55954_CR47","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1046\/j.1471-4159.1995.65062690.x","volume":"65","author":"L Minghetti","year":"1995","unstructured":"Minghetti, L. & Levi, G. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J. Neurochem. 65, 2690\u20132698 (1995).","journal-title":"J. Neurochem."},{"key":"55954_CR48","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0300-9084(00)88886-0","volume":"80","author":"G Levi","year":"1998","unstructured":"Levi, G., Minghetti, L. & Aloisi, F. Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions. Biochimie 80, 899\u2013904 (1998).","journal-title":"Biochimie"},{"key":"55954_CR49","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3389\/fimmu.2019.01170","volume":"10","author":"LW Bonham","year":"2019","unstructured":"Bonham, L. W., Sirkis, D. W. & Yokoyama, J. S. The transcriptional landscape of microglial genes in aging and neurodegenerative disease. Front. Immunol. 10, 1170 (2019).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55954-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:08:10Z","timestamp":1787872090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55954-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55954"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55954-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The cohort was approved by the Ethics Committee of Xiangyang No.1 People\u2019s Hospital, Hubei, China [approval No. XYYYE20230027]. All patients provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27010"}}